Gao, M. orcid.org/0009-0002-6457-8701, Saravanan, S., Munyombwe, T. et al. (4 more authors) (2025) Effects of Modern Glucose Monitoring and Insulin Delivery Technologies on Patient-Reported Outcomes and Experiences in Individuals With Type 1 Diabetes: A Systematic Review and Meta-analysis. Diabetes Care, 48 (12). dc251178. ISSN: 0149-5992
Abstract
BACKGROUND
Use of technology is central to the management of type 1 diabetes (T1D), while patient reported outcomes measures (PROMs) can support in the management of these individuals.
PURPOSE
To assess the effect of diabetes technologies on patient-reported outcome measures (PROMs) in type 1 diabetes (T1D).
DATA SOURCES
Cochrane Library CENTRAL, Embase, MEDLINE, Scopus, and Web of Science were searched for relevant articles from 2013 to August 2025.
STUDY SELECTION
We included longitudinal diabetes technology studies assessing validated PROMs in nonpregnant adults with T1D.
DATA EXTRACTION
Study characteristics and PROM data were extracted, and standardized mean differences (SMDs) for PROs were pooled using a random-effects meta-analysis.
DATA SYNTHESIS
We identified 4,885 articles, comprising 81 independent studies (n = 19,148 participants) and 70 different PROMs. The Hypoglycemia Fear Survey (HFS) was most commonly used (k = 39 studies), followed by the Diabetes Treatment Satisfaction Questionnaire (status [DTSQs] or change version [DTSQc]; k = 38), Diabetes Distress Scale (DDS; k = 25), and Problem Areas in Diabetes (PAID) scale (k = 24). Technology use was associated with lower HFS total score compared with control (SMD −0.177; 95% CI −0.319, −0.036; P = 0.014; I2 = 0.0%), with the largest effect observed in automated insulin device users. A moderate positive effect of diabetes technologies was observed on DTSQs and DTSQc scores (SMD 0.429; 95% CI 0.206, 0.653; P < 0.001; I2 = 72.3%), with a small to moderate reduction in DDS and PAID scores (SMD −0.265; 95% CI −0.363, −0.166; P < 0.001; I2 = 0.0%).
LIMITATIONS
Differences in type of technology, varied use and incomplete reporting of PROMs, and different duration of studies.
CONCLUSIONS
Diabetes technologies offer psychological benefits in adults with T1D. The large number of reported PROMs suggests a need to standardize their use.
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | This is an author produced version of an article published in Diabetes Care made available under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. |
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) |
| Date Deposited: | 12 Nov 2025 16:30 |
| Last Modified: | 17 Nov 2025 16:01 |
| Status: | Published |
| Publisher: | American Diabetes Association |
| Identification Number: | 10.2337/dc25-1178 |
| Related URLs: | |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:234189 |
Download
Filename: T1D_Sys_Manuscript_revision 1_MG-RA-CLEAN (002).docx
Licence: CC-BY 4.0

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)